发明名称 |
ORALLY DISINTEGRATED DOSAGE FORM |
摘要 |
<p>The present invention features an orally disintegrating dosage form including from about 5% to about 40%, by weight, of at least one hydrated salt and a pharmaceutically active agent, wherein the at least hydrated salt has a dehydration temperature of from about 20 to about 120 °C.</p> |
申请公布号 |
WO2009058798(A2) |
申请公布日期 |
2009.05.07 |
申请号 |
WO2008US81496 |
申请日期 |
2008.10.29 |
申请人 |
MCNEIL-PPC, INC.;BUNICK, FRANK;LUBER, JOSEPH |
发明人 |
BUNICK, FRANK;LUBER, JOSEPH |
分类号 |
A61K9/20 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|